BioCentury
ARTICLE | Company News

Egalet, Shionogi deal

December 14, 2015 8:00 AM UTC

Shionogi terminated a 2013 deal to develop and commercialize oral abuse-deterrent hydrocodone opioid products using Egalet’s drug delivery technology, including S-718632. Egalet said the termination ...